JP2023522405A5 - - Google Patents
Info
- Publication number
- JP2023522405A5 JP2023522405A5 JP2022564280A JP2022564280A JP2023522405A5 JP 2023522405 A5 JP2023522405 A5 JP 2023522405A5 JP 2022564280 A JP2022564280 A JP 2022564280A JP 2022564280 A JP2022564280 A JP 2022564280A JP 2023522405 A5 JP2023522405 A5 JP 2023522405A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- compound
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2005858.2 | 2020-04-22 | ||
| GBGB2005858.2A GB202005858D0 (en) | 2020-04-22 | 2020-04-22 | H4 Antagonist compounds |
| PCT/GB2021/050971 WO2021214469A1 (en) | 2020-04-22 | 2021-04-22 | H4 antagonist compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522405A JP2023522405A (ja) | 2023-05-30 |
| JP2023522405A5 true JP2023522405A5 (https=) | 2024-05-02 |
| JP7671307B2 JP7671307B2 (ja) | 2025-05-01 |
Family
ID=70859977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022564280A Active JP7671307B2 (ja) | 2020-04-22 | 2021-04-22 | Ｈ４アンタゴニスト化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230167094A1 (https=) |
| EP (1) | EP4139300A1 (https=) |
| JP (1) | JP7671307B2 (https=) |
| KR (1) | KR20230004512A (https=) |
| CN (1) | CN115916770B (https=) |
| AU (1) | AU2021260142A1 (https=) |
| BR (1) | BR112022021395A2 (https=) |
| CA (1) | CA3180853A1 (https=) |
| GB (1) | GB202005858D0 (https=) |
| IL (1) | IL297469A (https=) |
| MX (1) | MX2022013340A (https=) |
| WO (1) | WO2021214469A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005054239A1 (en) * | 2003-12-05 | 2005-06-16 | Bayer Healthcare Ag | 2-aminopyrimidine derivatives |
| NL2000323C2 (nl) * | 2005-12-20 | 2007-11-20 | Pfizer Ltd | Pyrimidine-derivaten. |
| US20100035863A1 (en) * | 2006-09-12 | 2010-02-11 | Ucb Pharma, S.A. | 2 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical Compositions |
| US7985745B2 (en) | 2006-10-02 | 2011-07-26 | Abbott Laboratories | Method for pain treatment |
| CL2008000467A1 (es) * | 2007-02-14 | 2008-08-22 | Janssen Pharmaceutica Nv | Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma |
| WO2009068512A1 (en) * | 2007-11-30 | 2009-06-04 | Palau Pharma, S. A. | 2 -amino-pyrimidine derivatives as histamine h4 antagonists |
| PE20091524A1 (es) * | 2007-12-19 | 2009-09-25 | Palau Pharma Sa | Derivados de 2-aminopirimidina |
| GB201817047D0 (en) * | 2018-10-19 | 2018-12-05 | Heptares Therapeutics Ltd | H4 antagonist compounds |
-
2020
- 2020-04-22 GB GBGB2005858.2A patent/GB202005858D0/en not_active Ceased
-
2021
- 2021-04-22 IL IL297469A patent/IL297469A/en unknown
- 2021-04-22 AU AU2021260142A patent/AU2021260142A1/en active Pending
- 2021-04-22 WO PCT/GB2021/050971 patent/WO2021214469A1/en not_active Ceased
- 2021-04-22 CA CA3180853A patent/CA3180853A1/en active Pending
- 2021-04-22 MX MX2022013340A patent/MX2022013340A/es unknown
- 2021-04-22 KR KR1020227036308A patent/KR20230004512A/ko not_active Withdrawn
- 2021-04-22 US US17/920,583 patent/US20230167094A1/en active Pending
- 2021-04-22 CN CN202180030226.4A patent/CN115916770B/zh active Active
- 2021-04-22 EP EP21722982.2A patent/EP4139300A1/en active Pending
- 2021-04-22 BR BR112022021395A patent/BR112022021395A2/pt not_active Application Discontinuation
- 2021-04-22 JP JP2022564280A patent/JP7671307B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7379680B2 (ja) | テルフェニル化合物の新規な塩 | |
| SI2956452T1 (en) | Heterocyclic amides as kinase inhibitors | |
| BR112017007953B1 (pt) | Forma cristalina ii do bissulfato inibidor de jak quinase, seu uso e seu método de preparação, e composição farmacêutica | |
| JP2020511461A5 (https=) | ||
| US10071999B2 (en) | Crystalline forms of (3-amino-oxetan-3-ylmethyl)-[2-(5,5-dioxo-5,6,7,9-tetrahydro-5lambda*6*-thia-8-aza-benzocyclohepten-8-yl)-6-methyl-quinazolin-4-yl]-amine | |
| JP6937322B2 (ja) | 置換ピペリジン化合物の塩 | |
| CN103965116B (zh) | 半5-氟胞嘧啶盐、其制备方法及应用 | |
| GB2558514A (en) | Process for the synthesis of stable amorphous ibrutinib | |
| CN121045220A (zh) | Janus激酶抑制剂的晶体形式 | |
| JP2023522405A5 (https=) | ||
| TW202404604A (zh) | [(1S)-1-[(2S,4R,5R)-5-(5-胺基-2-酮基-噻唑并[4,5-d]嘧啶-3-基)-4-羥基-四氫呋喃-2-基]丙基]乙酸酯之新穎固態形式 | |
| CN110944979A (zh) | Odm-201晶型及其制备方法和药物组合物 | |
| JP2017507994A (ja) | チアクマイシンｂの新たな多形及び新たな固体状態 | |
| ES2671126T3 (es) | Formas sólidas estables de enclomifeno y citrato de enclomifeno | |
| DE69322030T2 (de) | Kristallisiertes Dihydrat eines Cephalosporin-Dihydrochlorids und seine injizierbaren Zusammensetzungen | |
| KR20160095171A (ko) | 피라지노[２,１－ｃ][１,２,４]트리아진 화합물의 결정 (２) | |
| JP2024546098A5 (https=) | ||
| TWI707851B (zh) | 哌嗪化合物的新穎結晶 | |
| WO2018078383A1 (en) | Pharmaceutical composition comprising amorphous selexipag | |
| KR20090044694A (ko) | 모사프리드의 신규한 동질이상체 및 유사동질이상체 | |
| Chadha et al. | Retrospection on polymorphism and cocrystallization of anti-retrovirals | |
| ES2981595T3 (es) | Sales de adición de ácido selectivas del antagonista H3 de histamina y procedimiento para la preparación de las mismas | |
| Krūkle-Bērziņa et al. | Investigation of the phase transitions occurring during and after the dehydration of xylazine hydrochloride monohydrate | |
| Yang et al. | The features of the crystal structure of the layered series hydrates of uridine-5′-monophosphate salts (UMPNa x· y H 2 O) | |
| EP3710425A1 (en) | Solid state forms of elafibranor |